Bayrak EBT Taban Sanayi ve Ticaret Anonim Sirketi Past Earnings Performance
Past criteria checks 0/6
Bayrak EBT Taban Sanayi ve Ticaret Anonim Sirketi's earnings have been declining at an average annual rate of -43.2%, while the Chemicals industry saw earnings growing at 34% annually. Revenues have been growing at an average rate of 44.6% per year.
Key information
-43.2%
Earnings growth rate
-42.4%
EPS growth rate
Chemicals Industry Growth | 50.0% |
Revenue growth rate | 44.6% |
Return on equity | -36.3% |
Net Margin | -34.8% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bayrak EBT Taban Sanayi ve Ticaret Anonim Sirketi makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 148 | -51 | 22 | 0 |
30 Jun 24 | 232 | -15 | 23 | 0 |
31 Mar 24 | 250 | 19 | 29 | 0 |
31 Dec 23 | 293 | 26 | 31 | 0 |
30 Sep 23 | 497 | -41 | 47 | 0 |
30 Jun 23 | 394 | -54 | 40 | 0 |
31 Mar 23 | 359 | -41 | 30 | 0 |
31 Dec 22 | 279 | -34 | 22 | 0 |
30 Sep 22 | 119 | 5 | 11 | 0 |
30 Jun 22 | 99 | 5 | 10 | 0 |
31 Mar 22 | 73 | 3 | 8 | 0 |
31 Dec 21 | 68 | 5 | 6 | 0 |
30 Sep 21 | 62 | 4 | 4 | 0 |
30 Jun 21 | 55 | 3 | 3 | 0 |
31 Mar 21 | 43 | 4 | 4 | 0 |
31 Dec 20 | 38 | 4 | 4 | 0 |
30 Sep 20 | 37 | 3 | 3 | 0 |
30 Jun 20 | 36 | 4 | 3 | 0 |
31 Mar 20 | 40 | 5 | 3 | 0 |
31 Dec 19 | 39 | 4 | 3 | 0 |
31 Dec 18 | 29 | 3 | 4 | 0 |
31 Dec 17 | 31 | 3 | 3 | 0 |
Quality Earnings: BAYRK is currently unprofitable.
Growing Profit Margin: BAYRK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BAYRK is unprofitable, and losses have increased over the past 5 years at a rate of 43.2% per year.
Accelerating Growth: Unable to compare BAYRK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BAYRK is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-23.2%).
Return on Equity
High ROE: BAYRK has a negative Return on Equity (-36.26%), as it is currently unprofitable.